Nippon Life Global Investors Americas, Inc. Gilead Sciences, Inc. Transaction History

Nippon Life Global Investors Americas, Inc.

$2.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $8.28 Million - $10.4 Million	-142,890 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $753,256 - $854,960	11,610 Added 8.84%	142,890 $10.4 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $1.3 Million - $1.4 Million	-19,230 Reduced 12.78%	131,280 $9.17 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $538,225 - $588,088	-8,480 Reduced 5.33%	150,510 $10.4 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $170,400 - $194,426	2,840 Added 1.82%	158,990 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $864,432 - $1.09 Million	13,920 Added 9.79%	156,150 $9.87 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $7.81 Million - $9.07 Million	107,940 Added 314.79%	142,230 $10.9 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $4.49 Million - $5.75 Million	-71,686 Reduced 67.64%	34,290 $2.56 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $812,151 - $893,340	13,180 Added 14.2%	105,976 $6.89 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $247,480 - $277,520	4,000 Added 4.5%	92,796 $6.27 Million
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $259,499 - $290,707	-4,150 Reduced 4.46%	88,796 $5.77 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $7.05 Million - $9.21 Million	-116,530 Reduced 55.63%	92,946 $5.81 Million
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $2.91 Million - $3.22 Million	-40,840 Reduced 16.32%	209,476 $16.2 Million
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $2.68 Million - $3.12 Million	-41,230 Reduced 14.14%	250,316 $17.7 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $2.01 Million - $2.45 Million	-27,580 Reduced 8.64%	291,546 $22 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $2.09 Million - $2.45 Million	29,310 Added 10.11%	319,126 $22.9 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $20.9 Million - $24.8 Million	289,816	289,816 $23.5 Million

Others Institutions Holding GILD

# of Institutions

1,928

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account